Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
361-02-005 ISMRM Abstract

MRI Guided Minimally Invasive Prostate Cancer Cryoablation: Initial Clinical Outcomes

Primary: Interventional - MR-Guided Interventions
Secondary: Body - Prostate
361-02-005 · Prostate: Clinical Applications, AI, and Post-Processing · Monday, 11 May, 9:15 AM–10:10 AM · Digital Posters Row B
Keywords: Cancer Prostate MR guided cryoablation
Accepted
Lauren C Marlatt 1, Thomas Lilieholm2, Michael Risk3, David F Jarrard3, Erica Knavel-Koepsel1
1Department of Interventional Radiology, University of Wisconsin School of Medicine and Public Health, Madison, United States of America
2Medical Physics, University of Wisconsin - Madison, Madison, United States of America
3Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, United States of America
Presenting Author: Lauren C Marlatt

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, Horwitz EM. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer. 2008 Jan 1;112(1):55-60. doi: 10.1002/cncr.23139. PMID: 17968996. [doi] [pmid]
2. Bahn DK, Silverman P, Lee F Sr, Badalament R, Bahn ED, Rewcastle JC. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol. 2006 Sep;20(9):688-92. doi: 10.1089/end.2006.20.688. PMID: 16999628. [doi] [pmid]
3. Karwacki J, Kiełbasa J, Szczepaniak Z, Zagórski K, Kobylański M, Gurwin A, Patrzałek P, Janczak D, Krajewski W, Szydełko T, Małkiewicz B. Current Status of Cryoablation in Prostate Cancer Management. Clin Med Insights Oncol. 2025 Jul 3;19:11795549251350830. doi: 10.1177/11795549251350830. PMID: 40620664; PMCID: PMC12227874. [doi] [pmid]
4. Kongnyuy, M., Islam, S., Mbah, A.K. et al. PSA kinetics following primary focal cryotherapy (hemiablation) in organ-confined prostate cancer patients. World J Urol 36, 209–213 (2018). https://doi.org/10.1007/s00345-017-2130-5 [doi]
5. Lilieholm T., Block W.F., Koepsel E.K., Magnetic resonance imaging for computer-assisted device guidance in transperineal prostate biopsy and cryoablation. Transl Androl Urol 2025;14(4):928-939. doi: 10.21037/tau-2024-635 [doi]
6. Mao X, Mei R, Yu S, Shou L, Zhang W, Li K, Qiu Z, Xie T, Sui X. Emerging Technologies for the Detection of Cancer Micrometastasis. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221100355. doi: 10.1177/15330338221100355. PMID: 35903930; PMCID: PMC9340332. [doi] [pmid]
7. Moreira, P., K. Tuncali, C. M. Tempany, and J. Tokuda. The impact of placement errors on the tumor coverage in MRI-guided focal cryoablation of prostate cancer. Academic Radiology. 28:841–848, 2021. https://doi.org/10.1016/j.acra.2020.07.013. [doi]
8. Overduin, C.G., Jenniskens, S.F.M., Sedelaar, J.P.M. et al. Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes. Eur Radiol 27, 4828–4836 (2017). https://doi.org/10.1007/s00330-017-4833-9 [doi]
9. Woodrum DA, Gorny KR, Mynderse LA. MR-Guided Prostate Interventions. Top Magn Reson Imaging 2018;27:141-51. 10.1097/RMR.0000000000000155 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/361-02-005